German A. Pihan
Research Subjects
German A. Pihan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Adam Bagg
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
1 shared publication - Alexa J. Siddon
Departments of Pathology & Laboratory Medicine, Yale School of Medicine , New Haven, CT
1 shared publication Anneliese Carrascoso
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA
1 shared publication- Anupriya Agarwal
Division of Oncological Sciences, Oregon Health & Science University, United States
1 shared publication - Benjamin L. Ebert
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
1 shared publication Carlos E. Bueso-Ramos
Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, United States
1 shared publication
Latest Publications
- Open Access
- 1 December 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (23) , 7304-7318
Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice
Germ line mutations in the RUNX1 gene cause familial platelet disorder (FPD), an inherited disease associated with lifetime risk to hematopoietic malignancies (HM). Patients with FPD frequently show clonal expansion of premalignant cells preceding HM onset. Despite the extensive studies on the role of RUNX1 in hematopoiesis, its function in the premalignant bone marrow (BM) is not well-understood. Here, we characterized the hematopoietic progenitor compartments using a mouse strain carrying an FPD-associated mutation, Runx1R188Q. Immunophenotypic analysis showed an increase in the number of hematopoietic stem and progenitor cells (HSPCs) in the Runx1R188Q/+ mice. However, the comparison of Sca-1 and CD86 markers suggested that Sca-1 expression may result from systemic inflammation. Cytokine profiling confirmed the dysregulation of interferon-response cytokines in the BM. Furthermore, the expression of CD48, another inflammation-response protein, was also increased in Runx1R188Q/+ HSPCs. The DNA-damage response activity of Runx1R188Q/+ hematopoietic progenitor cells was defective in vitro, suggesting that Runx1R188Q may promote genomic instability. The differentiation of long-term repopulating HSCs was reduced in Runx1R188Q/+ recipient mice. Furthermore, we found that Runx1R188Q/+ HSPCs outcompete their wild-type counterparts in bidirectional repopulation assays, and that the genetic makeup of recipient mice did not significantly affect the clonal dynamics under this setting. Finally, we demonstrate that Runx1R188Q predisposes to HM in cooperation with somatic mutations found in FPDHM, using 3 mouse models. These studies establish a novel murine FPDHM model and demonstrate that germ line Runx1 mutations induce a premalignant phenotype marked by BM inflammation, selective expansion capacity, defective DNA-damage response, and predisposition to HM.
- 1 December 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (23) , 7304-7318
Open AccessRunx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice
Germ line mutations in the RUNX1 gene cause familial platelet disorder (FPD), an inherited disease associated with lifetime risk to hematopoietic malignancies (HM). Patients with FPD frequently show clonal expansion of premalignant cells preceding HM onset. Despite the extensive studies on the role of RUNX1 in hematopoiesis, its function in the premalignant bone marrow (BM) is not well-understood. Here, we characterized the hematopoietic progenitor compartments using a mouse strain carrying an FPD-associated mutation, Runx1R188Q. Immunophenotypic analysis showed an increase in the number of hematopoietic stem and progenitor cells (HSPCs) in the Runx1R188Q/+ mice. However, the comparison of Sca-1 and CD86 markers suggested that Sca-1 expression may result from systemic inflammation. Cytokine profiling confirmed the dysregulation of interferon-response cytokines in the BM. Furthermore, the expression of CD48, another inflammation-response protein, was also increased in Runx1R188Q/+ HSPCs. The DNA-damage response activity of Runx1R188Q/+ hematopoietic progenitor cells was defective in vitro, suggesting that Runx1R188Q may promote genomic instability. The differentiation of long-term repopulating HSCs was reduced in Runx1R188Q/+ recipient mice. Furthermore, we found that Runx1R188Q/+ HSPCs outcompete their wild-type counterparts in bidirectional repopulation assays, and that the genetic makeup of recipient mice did not significantly affect the clonal dynamics under this setting. Finally, we demonstrate that Runx1R188Q predisposes to HM in cooperation with somatic mutations found in FPDHM, using 3 mouse models. These studies establish a novel murine FPDHM model and demonstrate that germ line Runx1 mutations induce a premalignant phenotype marked by BM inflammation, selective expansion capacity, defective DNA-damage response, and predisposition to HM.
- 28 September 2022
- Published by Elsevier in Leukemia Research
- Vol. 123, 106965
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype
- 28 September 2022
- Published by Elsevier in Leukemia Research
- Vol. 123, 106965
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype
- Open Access
- 1 March 2020
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 19, 100599
Nerve root biopsy in intramedullary spinal cord lymphoma: Technical note and case report
- 1 March 2020
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 19, 100599
Open AccessNerve root biopsy in intramedullary spinal cord lymphoma: Technical note and case report
- 15 February 2006
- Published by Wiley in European Journal of Haematology
- Vol. 76 (5) , 432-435
A novel mutation in the last exon of ATRX in a patient with α‐thalassemia myelodysplastic syndrome
Abstract: We describe a patient with acquired alpha‐thalassemia myelodysplastic syndrome (ATMDS). A previously healthy 66‐year‐old man presented with hemoglobin of 9.3 g/dL, mean corpuscular volume 59 fL, and a bone marrow aspirate with increased erythroid precursors and hypolobulated megakaryocytes. Hemoglobin H inclusions were seen in most red cells after 1% brilliant cresyl blue supravital stain of the peripheral blood. At the molecular level, we identified of a novel mutation in the most 3′ exon of the ATRX gene (CGA→TGA substitution in codon 2407) resulting in a premature termination codon (p.R2407X). This case provides further evidence for a link between ATRX mutations and ATMDS, and suggests a possible role for the conserved Q‐box element in ATRX function.
- 15 February 2006
- Published by Wiley in European Journal of Haematology
- Vol. 76 (5) , 432-435
A novel mutation in the last exon of ATRX in a patient with α‐thalassemia myelodysplastic syndrome
Abstract: We describe a patient with acquired alpha‐thalassemia myelodysplastic syndrome (ATMDS). A previously healthy 66‐year‐old man presented with hemoglobin of 9.3 g/dL, mean corpuscular volume 59 fL, and a bone marrow aspirate with increased erythroid precursors and hypolobulated megakaryocytes. Hemoglobin H inclusions were seen in most red cells after 1% brilliant cresyl blue supravital stain of the peripheral blood. At the molecular level, we identified of a novel mutation in the most 3′ exon of the ATRX gene (CGA→TGA substitution in codon 2407) resulting in a premature termination codon (p.R2407X). This case provides further evidence for a link between ATRX mutations and ATMDS, and suggests a possible role for the conserved Q‐box element in ATRX function.